India’s First CAR T-Cell Therapy Shows Durable Results: Two-Year Remission Achieved in Blood Cancer Patients
Breakthrough data from Immuneel Therapeutics shows sustained remission in multiple patients treated with Varnimcabtagene autoleucel (IMN-003A) • Seven patients surpass two-year progression-free survival (PFS), a national first known for Indian CAR T therapy • Benchmark…